Pharmacogenetic Testing

The contract titled "Pharmacogenetic Testing" issued by Piedmont Geriatric Hospital in Virginia aims to provide specialized genetic testing services to patients, focusing on analyzing genetic factors that influence individual responses to medications. The solicitation, posted on June 27, 2024, with a deadline for responses set for July 17, 2024, seeks qualified vendors capable of delivering accurate and reliable pharmacogenetic testing. The scope of work emphasizes the need for comprehensive testing capabilities, including specimen collection, processing, and reporting, with an emphasis on ensuring high standards of quality, security, and compliance with relevant medical and laboratory standards. The contract is managed by Allison Maddox, who can be contacted via email or phone for further inquiries. Supporting documentation highlights the importance of vendor qualification and compliance, requiring registration with the Virginia State Corporation Commission, submission of a Vendor Data Sheet detailing experience and capabilities, and adherence to specific operational standards. The scope of work specifies that the testing must be performed using validated laboratory methods, with results communicated securely and efficiently through a cloud-based Data Management System. This system must facilitate specimen tracking, reporting, and administrative oversight, ensuring timely and accurate delivery of results. Overall, the contract underscores the Virginia agency’s commitment to enhancing personalized medicine through reliable pharmacogenetic testing services, with a focus on vendor capability, regulatory compliance, and operational excellence.